AP2296A - Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile. - Google Patents

Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.

Info

Publication number
AP2296A
AP2296A AP2007003934A AP2007003934A AP2296A AP 2296 A AP2296 A AP 2296A AP 2007003934 A AP2007003934 A AP 2007003934A AP 2007003934 A AP2007003934 A AP 2007003934A AP 2296 A AP2296 A AP 2296A
Authority
AP
ARIPO
Prior art keywords
amino
cyanoethenyl
benzonitrile
dimethylphenyl
pyrimidinyl
Prior art date
Application number
AP2007003934A
Other versions
AP2007003934A0 (en
Inventor
Paul Theodoor Agnes Stevens
Jozef Peeters
Roger Petrus Gerebern Vandecruys
Original Assignee
Janssen Pharmaceutica Nv
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38137294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2296(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from MYPI20043578A external-priority patent/MY169670A/en
Application filed by Janssen Pharmaceutica Nv, Tibotec Pharm Ltd filed Critical Janssen Pharmaceutica Nv
Priority claimed from PCT/EP2005/054342 external-priority patent/WO2006024668A1/en
Publication of AP2007003934A0 publication Critical patent/AP2007003934A0/en
Application granted granted Critical
Publication of AP2296A publication Critical patent/AP2296A/en

Links

AP2007003934A 2004-09-02 2005-09-02 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile. AP2296A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20043578A MY169670A (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors
PCT/EP2005/054342 WO2006024668A1 (en) 2004-09-02 2005-09-02 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile

Publications (2)

Publication Number Publication Date
AP2007003934A0 AP2007003934A0 (en) 2007-04-30
AP2296A true AP2296A (en) 2011-10-31

Family

ID=38137294

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007003934A AP2296A (en) 2004-09-02 2005-09-02 Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.

Country Status (6)

Country Link
CN (2) CN101056673A (en)
AP (1) AP2296A (en)
CR (1) CR9031A (en)
SG (1) SG155885A1 (en)
UA (2) UA92469C2 (en)
ZA (1) ZA200701826B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170421A1 (en) * 2012-05-14 2013-11-21 上海迪赛诺药业有限公司 Rilpivirine hydrochloride alcoholate polymorph and preparation method thereof
CN103420920B (en) * 2012-05-14 2016-04-27 上海迪赛诺药业有限公司 Rilpivrine hydrochloride alcoholate polymorphic form and preparation method thereof
DK3528791T3 (en) * 2016-10-24 2024-01-29 Janssen Sciences Ireland Unlimited Co DISPERGIBLE COMPOSITIONS

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016306A1 (en) * 2001-08-13 2003-02-27 Janssen Pharmaceutica N.V. Hiv inhibiting pyrimidines derivatives
WO2004016581A1 (en) * 2002-08-09 2004-02-26 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016306A1 (en) * 2001-08-13 2003-02-27 Janssen Pharmaceutica N.V. Hiv inhibiting pyrimidines derivatives
WO2004016581A1 (en) * 2002-08-09 2004-02-26 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Also Published As

Publication number Publication date
AP2007003934A0 (en) 2007-04-30
CN101056673A (en) 2007-10-17
UA92469C2 (en) 2010-11-10
ZA200701826B (en) 2008-07-30
SG155885A1 (en) 2009-10-29
UA92467C2 (en) 2010-11-10
CN101068597B (en) 2012-04-18
CN101068597A (en) 2007-11-07
CR9031A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
HK1081527A1 (en) Processes for the preparation of 4-[4-[4-(2-cyanoethenyl)-2,6- dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
CY2016050I1 (en) 4-[[4-[[4-(2-CYANOETHENYL)-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRIUM SALT
PL1632232T3 (en) Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
IL202363A0 (en) Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
NO2014032I1 (en) (E) -4 - [[4 - [[4- (2-cyanoethenyl) -2,6-dimethylphenylamino] -2-pyrimidinyl] amino] benzonitrile Rilpivirine) and any therapeutically equivalent form thereof protected of the present patent such as pharmaceutically acceptable salts including the hydrochloride salt of Rilpiverine; tenofovir and especially tenofovir disproxil fumatate and emtricitabine.
IL181056A (en) 2,4- phenyl amine, 5-substituted pyrimidine compounds and pharmaceutical compositions comprising them
AP2296A (en) Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.
AP2487A (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
HK1112862A1 (en)